Last update Feb. 21, 2025
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Tramazoline Hydrochloride in other languages or writings:
Tramazoline Hydrochloride belongs to these groups or families:
Main tradenames from several countries containing Tramazoline Hydrochloride in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Sympathomimetic with alpha adrenergic activity. It has vasoconstrictor effect that reduces edema and mucosal congestion. Topical nasal or ophthalmologic use (2 - 3 times a day).
At the date of last update we found no published data in relation to breastfeeding.
The small dose and the low plasmatic absorption of most nasal or ophthalmologic topical preparations make unlikely the passage of significant amount into breast milk.
Do not exceed recommended doses and time to avoid undesirable side effects and the possible decrease in milk cited by some authors (Nice 2000) for other similar drugs, although not proven in practice.
Product with very few bibliographic references and almost none on pharmacokinetics. As a nasal decongestant it is not recommended by some authors (Nice 2000), being preferable drugs of the same group better known. (Anderson 2000)
Ophthalmic administration is totally compatible with breastfeeding. Absorption can be minimized by pressing with the finger on the tear duct (inner canthus of the eye) for 1 minute.
Some authors consider oral and nasal decongestant drugs dispensable medications, to be avoided in general, not only during breastfeeding, as they expose patients to serious risks (cardiovascular, neurological and intestinal) to treat a benign alteration such as nasal obstruction, which usually evolves favorably in a few days without medication. (Prescrire 2018)
In 2025 a mother wrote to us: “only used once before bedtime at night for two days and decreased breast milk is appreciated and the baby sleeps worse, possible insomnia”.